|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22,400 KRW | +0.22% |
|
+1.13% | -12.84% |
Kolon Life Science Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 50.44 million compared to KRW 27.26 million a year ago. Net loss was KRW 4,660.01 million compared to KRW 2,860.79 million a year ago.
Basic loss per share from continuing operations was KRW 650 compared to KRW 223 a year ago. Basic loss per share was KRW 408 compared to KRW 251 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -12.84% | 187M | |
| +31.08% | 588B | |
| -3.32% | 364B | |
| +19.45% | 326B | |
| +5.02% | 285B | |
| +15.53% | 239B | |
| +10.09% | 210B | |
| -7.08% | 200B | |
| +9.23% | 167B | |
| -0.43% | 161B |
KOLON LIFE SCIENCE INC. 
